$HBAN

Huntington Bancshares Q2 Earnings Call Highlights

Huntington Bancshares management said it is on track for $365 million in Cadence cost synergies in Q4 and $435 million in combined Veritex and Cadence run-rate expense synergies by Q4. Q2 average loans rose $15B (8.6%) and deposits rose $18.8B (9.2%). Net interest income was $2.1B (+8.5%); value-added fees rose over 60% YoY. Outlook: NII pressured by deposit costs; EPS target for 2027 is $1.90 to $1.93.

Original reporting
Published Jul 24, 2026, 11:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 12:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huntington Bancshares Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$HBANNeutralMed
01

Why it matters

Traders can update models around the near-term NII trough, NIM path (low-320s in Q3, mid-to-high-320s in Q4), and credit expectations (charge-offs lower half of the 25 to 35 bps range), while monitoring fee momentum and operating leverage.

02

Market read

The call provides concrete guidance on NII pressure and NIM recovery timing, plus fee upside and synergy execution, which are key inputs for near-term earnings estimates.

03

What to watch

The guidance hinges on fixed-asset repricing, liquidity optimization, and Cadence deposit actions; any slippage in those levers could delay NIM recovery into Q4.

Relevance 7/10Novelty 7/10Timing: post-Q2 earnings call, ahead of Q3 results and estimate revisions

Background

The article summarizes management commentary from Huntington Bancshares’ Q2 earnings call, including synergy progress from the Cadence combination and updated outlook.

Company-level read

Ticker impact

$HBANNeutralMedium confidence
Context

Huntington guided Q3 NII to the bottom of its range or slightly below, citing deposit cost pressure, while expecting NIM to rise into the low-320s.

Expected impact

Near-term downside risk to earnings expectations from NII pressure, partially offset by fee strength and reiterated 2027 targets.

Evidence & confidence

The article includes specific management guidance for NII/NIM trajectory, fee growth, synergy run-rates, and updated charge-off expectations, which can drive estimate revisions and positioning.

Market effects

Super-regional bank read-through on deposit-cost pressure and the balance between spread compression and fee diversification.

Limited direct regional spillover beyond US bank sentiment around NII sensitivity.

Low. Primarily US rates and bank-specific execution signals.

Counterpoint

Fee strength may not fully offset NII margin pressure if deposit costs remain elevated beyond management’s assumed trough timing.

Key entities

  • Huntington Bancshares

    Super-regional bank providing Q2 results commentary, synergy run-rate targets, and 2027 EPS and ROTCE targets.

  • Zach Wasserman

    CFO quoted on loan and deposit growth, NII/NIM outlook, fee growth, and credit/capital expectations.

  • Cadence

    Acquired franchise referenced for synergy run-rate and deposit portfolio actions impacting NII and NIM.

  • Veritex

    Referenced in the combined Veritex and Cadence expense synergy run-rate target.

Related articles

$HBANMed

HUNTINGTON BANCSHARES INC /MD/ (HBAN): Results of Operations and Financial Condition

HUNTINGTON BANCSHARES INC /MD/ (HBAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 hban20260630_8kex992.htm EX-99.2 Document Exhibit 99.2 HUNTINGTON BANCSHARES INCORPORATED Quarterly Financial Supplement June 30, 2026 Table of Contents Quarterly Key Statistics 1 Year-to-Date Key Statistics 2 Consolidated Balance Sheets 4 Loans and Leases Composition 5

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.